2. 您的位置
3. 首页
4. 会议论文
5. Relationship of histopathologic subtype with 18F-FDG uptake and EGFR mutations in lung adenocarcinom

Relationship of histopathologic subtype with 18F-FDG uptake and EGFR mutations in lung adenocarcinom

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：flish_mh

【摘 要】

：

　　Objective: The aim of this study is to investigate the correlation of histopathologic subtypes with epidermal growth factor receptor (EGFR) mutations and 18

【作 者】

：

Guangliang Qiang Chaoyang Liang Deruo Liu Yongqing Guo Bin Shi Jue Yan Rui Xu Yanyan Xu Ye Wang Jiping Da 

【机 构】

：

Department of Thoracic Surgery, China-Japan Friendship Hospital

【出 处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective: The aim of this study is to investigate the correlation of histopathologic subtypes with epidermal growth factor receptor (EGFR) mutations and 18F-fluorodeoxyglucose (FDG) uptake in lung adenocarcinomas (ADCs).

其他文献

Prognostic significance of KRT 19 in lung cancer

　　Objective: Lung cancer is a heterogeneous group of malignancies with variable prognosis and is divided into two main groups, small cell lung cancer (SCLC) a

会议

Notch3 promotes chemoresistance by upregulting ALDH1 A1 and CD44 and induces autophagy in non-small

　　Objective: Acquiredresistance to standard chemotherapy causes treatment failure in patients with advanced non-small lung cancer (NSCLC).Cancer stem cells (C

会议

The treatment with dose-escalated icotinib after resistance to routine dose of icotinib for the pati

　　Objective: To evaluate the efficacy of treatment with dose-escalated icotinib after resistance to routine dose of icotinib for the patients of the advanced

会议

Serum microRNA-139-5p is a biomarker of bone metastasis in lung cancer patient

　　Objective: Lung cancer is the leading cause of cancer mortality worldwide.About 30-40% of patients with lung cancer developed bone metastasis during the cou

会议

miR-1285-3p plays a tumor suppressor role in NSCLC by targeting YAP1

　　Objective: Non small cell lung cancer (NSCLC) is one of the most aggressive types of cancer and the leading cause of cancer mortality, yet the pathologic me

会议

Analysis of Prognostic Factors in 154 Patients with Small Cell Lung Cancer

　　Objective: To evaluate the survival of patients with small cell lung cancer and analyze the prognostic factors in these patients.Method: Clinical data were

会议

MiR-326 regulates cell proliferation and migration in lung cancer by targeting Phox2a and is regulat

　　Objective: MicroRNA plays a crucial role in development and progression of multiple malignancies.However, the mechanisms of microRNA in cancer are not total

会议

Combination of Angiogenesis Inhibitor (Endostar) and EGFR-TKIs in Patients with Advanced Non-small c

　　Objective: To evaluate the clinical activity of angiogenesis inhibitor Endostar (rh-endostatin) in combination with continued EGFR-TKIs (including erlotinib

会议

The role of antituberculosis treatment in patients with coexistence of lung cancer and pulmonary tub

　　Objective: The effects of antituberculosis treatment in patients with coexistence of lung cancer and pulmonary tuberculosis has not been known well.The aim

会议

The Relationship Between The Expression of Long Non-coding RNAs SCAND2 and KRAS as well as Its Clini

　　Objective: KRAS mutation was a poor prognostic factor in NSCLC, the patients with KRAS-MT has shorter survival than those of KRAS-WT.So it is urgentto furth

会议